antidiabetics


Also found in: Wikipedia.

antidiabetics

drugs used in the management of diabetes mellitus, including injected human analogue insulin, oral hypoglycaemic agents (e.g. biguanides; sulphonylureas), agents decreasing gut sugar absorption (e.g. acarbose), thiazolidinediones (TZDs, e.g. glitazones) reducing peripheral insulin resistance, agents that stimulate pancreatic insulin release (e.g. repaglinide) and exenatide (a synthetic gut hormone injected by those with type 2 diabetes to stimulate insulin secretion, decrease appetite, slow digestion and reduce gut carbohydrate absorption)
References in periodicals archive ?
The report has segmented the Turkish diabetes market into two segments - Insulin and the Oral Antidiabetics market.
com/research/24154e/pipeline_insight) has announced the addition of the "Pipeline Insight: Insulin Antidiabetics - Novel analogs show promise as alternative delivery methods prove less attractive.
21 /PRNewswire/ -- Since the advent of antidiabetic therapies such as insulin and oral antidiabetics, the major cause of diabetes- associated morbidity and mortality has been the long-term complications of diabetes rather than the disease itself.
com/research/e89683/pipeline_insight) has announced the addition of the "Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers" report to their offering.
The prospective development program covers selected products in such therapeutic categories as analgesics, cardiovascular agents, antidiabetics and antiasthmatics.
8 billion in 2019, the report quantifies the future size of the antidiabetics market over 2010-2019, features Januvia to become the leading franchise from 2012 after patent expiry of Actos, examines the future performance of leading antidiabetic brands, the growth of generics and insulin biosimilars, the opportunities for new products and the barriers to uptake for novel antidiabetic agents O http://marketpublishers.
In many cases, the required dose was lower than the doses of single agent glyburide or metformin, two commonly prescribed antidiabetics.
Analyze the historical, current and future trends in the Insulin and Oral Antidiabetics market to identify potential classes, drugs, partners and competitors for market entry and expansion plans.
The report has segmented the Brazilian diabetes market into two segments - Insulin and the Oral Antidiabetics market.
These drugs are valuable treatment options because they have been shown to lower a patient's blood sugar without hypoglycemia or an increase in body weight, common side effects of other antidiabetics.
Datamonitor expects the antidiabetics market to grow to $34.
The report has segmented the Italian diabetes market into two segments - Insulin and the Oral Antidiabetics market.